HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunological alterations and selectin values in hypertensive patients treated according to current criteria].

AbstractBACKGROUND AND OBJECTIVE:
To calculate the relationship of E and P selectins with immunological changes in essential hypertension.
PATIENTS AND METHOD:
We included 261 patients with essential hypertension with or without left ventricular hypertrophy (LVH), in whom selectins and specific cytokines were quantified.
RESULTS:
E-and P-selectins were increased in hypertension compared to controls [75(51) ng/mL versus 45(17) ng/mL, (p<0.0001) and 47(18) ng/mL versus 38(15) ng/mL, (p=0.049), respectively], as well as cytokine concentrations (p<0.0001). Furthermore, selectin values were significantly correlated with changes in immunological markers. The multivariate analysis showed that IL-1ra (p<0.0001) and P-selectin (p=0.013) were independent factors of E-selectin values. For P-selectin, IL-1ra (p=0.005), IL-8 (p<0.0001) and selectin-E (p=0.013) influenced on its concentration. Finally, selectin values were similar between patients with or without left ventricular hypertrophy.
CONCLUSIONS:
Immunological activation influenced on selectin concentrations in cardiologic asymptomatic patients with essential hypertension. LVH did not induce significant changes.
AuthorsRaquel Cortés, Manuel Portolés, Esther Roselló-Lletí, José Ramón González-Juanatey, Vicente Bertomeu, Miguel Rivera
JournalMedicina clinica (Med Clin (Barc)) Vol. 137 Issue 6 Pg. 254-6 (Sep 10 2011) ISSN: 1578-8989 [Electronic] Spain
Vernacular TitleAlteraciones inmunológicas y de los valores de selectinas en pacientes hipertensos tratados según criterios actuales.
PMID21145074 (Publication Type: Comparative Study, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier España, S.L. All rights reserved.
Chemical References
  • Antihypertensive Agents
  • Cytokines
  • E-Selectin
  • P-Selectin
Topics
  • Aged
  • Antihypertensive Agents (therapeutic use)
  • Asymptomatic Diseases
  • Comorbidity
  • Cross-Sectional Studies
  • Cytokines (blood)
  • Diabetes Complications (epidemiology)
  • Dyslipidemias (epidemiology)
  • E-Selectin (blood)
  • Female
  • Humans
  • Hypertension (blood, complications, drug therapy, immunology)
  • Hypertrophy, Left Ventricular (blood, etiology, immunology)
  • Male
  • Middle Aged
  • P-Selectin (blood)
  • Smoking (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: